Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 162

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Evaluation of pan‐ TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis‐like neural tumour and histological mimics

Hung, Yin P, Fletcher, Christopher D M, Hornick, Jason L · 2018 · Histopathology

Abstract

Aims: Infantile fibrosarcoma is characterised by intersecting fascicles of spindle cells and ETV 6 – NTRK 3 gene fusion in most cases. Given histological overlap with other spindle‐cell tumours, the diagnosis can be challenging and often requires molecular confirmation. A recently developed pan‐ TRK antibody shows promise for identifying tumours with NTRK fusions. The purpose of this study was to evaluate the potential diagnostic utility of pan‐ TRK immunohistochemistry for infantile fibrosarcoma. Methods and results: We evaluated whole‐tissue sections from 210 cases, including 15 infantile fibrosarcomas; five each lipofibromatosis‐like neural tumour and lipofibromatosis; 10 each primitive myxoid mesenchymal tumour of infancy ( PMMTI ) and low‐grade myofibroblastic sarcoma; 15 each fibrous hamartoma of infancy ( FHI ), myofibroma/myofibromatosis and desmoid‐type fibromatosis; and 20 each low‐grade fibromyxoid sarcoma, synovial sarcoma, spindle‐cell rhabdomyosarcoma, malignant peripheral nerve sheath tumour, fibrosarcomatous dermatofibrosarcoma protuberans (F‐ DFSP ) and nodular fasciitis. Immunohistochemistry was performed using a rabbit monoclonal pan‐ TRK antibody. Immunoreactivity for pan‐ TRK was observed in all 15 (100%) infantile fibrosarcomas, including diffuse immunoreactivity (>50% of cells) in 14 (93%) cases. Pan‐ TRK was positive in all five (100%) lipofibromatosis‐like neural tumours. Of the 190 histological mimics, diffuse pan‐ TRK immunoreactivity was noted in 16 (8%) cases, including five PMMTI , five FHI (highlighting predominantly the primitive myxoid spindle‐cell components), three F‐ DFSP , one low‐grade myofibroblastic sarcoma, one myofibroma and one spindle‐cell rhabdomyosarcoma. Conclusions: Diffuse pan‐ TRK immunoreactivity is a highly sensitive but not entirely specific diagnostic marker for infantile fibrosarcoma, and may be helpful in selecting patients for TRK ‐targeted therapy. As expected, lipofibromatosis‐like neural tumours, which harbour NTRK 1 fusions, also show diffuse pan‐ TRK immunoreactivity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/his.13666

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 162

Metadata

Authors
Hung, Y. P., Fletcher, C. D. M., & Hornick, J. L.
Venue
Histopathology
Publisher
Wiley
Published
2018-07-05
Volume
73
Issue
4
Pages
634-644
ISSN
  • 0309-0167 (ISSN-L)
  • 1365-2559
OpenAlex
W2807516814
Cited by
162
References
1
FWCI
14.88
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of pan‐ TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis‐like neural tumour and histological mimics. https://app.cochat.ai/papers/10.1111/his.13666
The paper
Hung, Y. P., Fletcher, C. D. M., & Hornick, J. L. (2018). Evaluation of pan‐ TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis‐like neural tumour and histological mimics. Histopathology. https://doi.org/10.1111/his.13666

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.